블로그
- FDA] FDA Advisory No.2026-0612 || Public Health Warning Against the Purchase and Use of the Co FDA Advisory No.2026-0612 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Updated: 2026-06-03 The Food and Drug Administration (FDA) advises the public against the purchase and
- 모티바가슴성형 결정하게 된 상담 과정 모티바가슴성형 결정하게 된 상담 과정 출처 : https://orangecountyplasticsurgery.com/motiva-breast-implants-2025-fda-approved-safety-data-and motivausa.com/patient/breast-implants 출처 : https://orangecountyplasticsurgery.com/motiva-breast-implants-2025-fda-approved-safety-data-and
- 가슴재수술 적합한 시기와 증상? 출처 : https://orangecountyplasticsurgery.com/motiva-breast-implants-2025-fda-approved-safety-data-and- motivausa.com/patient/breast-implants 출처 : https://orangecountyplasticsurgery.com/motiva-breast-implants-2025-fda-approved-safety-data-and
- [Philippines FDA] FDA Advisory No.2026-0706 || REGULATORY UPDATES FOR HOUSEHOLD/URBAN HAZARDOUS SUBS : 2026-06-29 The Food and Drug Administration (FDA). through the Center for Cosmetics and Household/Urban to the improvement of efficiency and service delivery.
- [Philippines FDA] FDA Advisory No.2026-0699 || PRODUCT RECALL OF AFFECTED STOCKS OF KOJIESAN SKIN LI FDA Advisory No.2026-0699 || PRODUCT RECALL OF AFFECTED STOCKS OF KOJIESAN SKIN LIGHTENING CLEANSER + (FDA) hereby informs all healthcare professionals and the general public regarding the recall of batch
- [Philippines FDA] FDA Advisory No.2026-0781|| Product Recall of Specific Batch of Nicardipine Hydroc FDA Advisory No.2026-0781|| Product Recall of Specific Batch of Nicardipine Hydrochloride 1 mg/mL Solution public are hereby warned by the Food and Drug Administration (FDA) that the affected batch of the pharmaceutical
- [Philippines FDA] FDA Advisory No.2026-0708 || INFORMATION ON BLEACH POISONING PREVENTION The Food and Drug Administration (FDA) thus provides information to the general public on the proper usage and storage of bleach products to promote awareness on bleach poisoning prevention.
- [Philippines FDA] FDA Advisory No.2026-0707 || QUALITY HOLD ON ALL BATCHES OF NICARDIPINE HYDROCHLOR FOR INJECTION (IV) [NICARIGHT, CARDILON, AND CARDIMED], 10 mL IMPORTED BY MEDETHIX, INC. Updated: 2026-06-30 In the interest of public health and safety, the Food and Drug Administration (FDA
- [U.S. FDA] FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufactur Food and Drug Administration announced the selection of seven companies to participate in the FDA PreCheck signed by President Trump in May 2025 and following a public meeting on challenges and opportunities
- [Philippines FDA] FDA Advisory No.2026-0705 || REMINDERS ON THE SAFE USE OF MUSICAL TOYS regarded as a universal language that children effortlessly enjoy and understand. To promote safe play and prevent injuries, the Food and Drug Administration (FDA) reminds the public